MedTrace Logo

Art Therapy Intervention for Breast Cancer Patients

NCT01220960 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2013-10-25

No results posted yet for this study

Summary

As studies continue to debate the effects of quality of life on survival, increased attention is being focused on investigating complementary alternative therapies to boost overall total health in cancer patients . Art therapy is an interesting growing field, which has shown promise to positively influence quality of life in the pediatric and adult oncology population alike. As there is a paucity of well controlled complete studies in this field, the investigators propose to study the impact of art therapy sessions in women with breast cancer with quantitative and qualitative analysis of emotional health and physical symptoms.

The results of the investigators study will have widespread applicability to oncology programs that wish to offer/implement such sessions to their palliative and non-palliative outpatients in an effort to address the important concept of whole person care.

Conditions

Interventions

OTHER

art therapy

Art therapy sessions, 2 hours in duration, 1 session/week, 8 continuous weeks of sessions. Each group will be limited to eight women as space is limited.

Sponsors & Collaborators

  • The Cedars Cancer Institute

    collaborator UNKNOWN

  • Dr. Sarkis Meterissian

    lead OTHER

Principal Investigators

  • Katherine L Laux, MA Art Therapy · Cedars CanSupport

  • Virginia Lee, PhD · McGill University Health Centre/Research Institute of the McGill University Health Centre

  • Sharon Wexler, PhD · Cedars CanSupport

  • Monisha Sudarshan, MD · McGill University Health Centre/Research Institute of the McGill University Health Centre

  • Sarkis Meterissian, PhD · MUHC Cedars Breast Centre

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2012-12-31
Completion
2013-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01220960 on ClinicalTrials.gov